at seekingalpha.com (Wed, 4-Mar 5:12 PM)
EyePoint Pharmaceuticals GAAP EPS of -$0.81 misses by $0.08, revenue of $0.62M misses by $0.39M
at seekingalpha.com (Wed, 4-Mar 7:04 AM)
Here are the major earnings before the open Wednesday
at seekingalpha.com (Tue, 3-Mar 6:00 PM)
EyePoint Pharmaceuticals Q4 2025 Earnings Preview
at seekingalpha.com (Tue, 3-Mar 10:31 AM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Mon, 2-Mar 5:00 PM)
Analysts’ Top Healthcare Picks: EyePoint Pharmaceuticals (EYPT), Astrana Health (ASTH)
at www.tipranks.com (Mon, 2-Mar 3:30 PM)
EyePoint Starts Global Phase 3 Trials for DURAVYU
at www.tipranks.com (Mon, 2-Mar 7:45 AM)
EyePoint’s Inducement Options Grant Signals Confidence Amid Advancing Retinal Drug Pipeline
Market Chameleon (Tue, 17-Feb 10:31 AM)
Market Chameleon (Tue, 17-Feb 7:54 AM)
